Rhumbline Advisers Science 37 Holdings, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
SELL
$0.21 - $0.39 $63,799 - $118,484
-303,806 Reduced 97.09%
9,109 $1,000
Q1 2023

May 11, 2023
BUY
$0.22 - $0.62 $889 - $2,505
4,041 Added 1.31%
312,915 $88,000
Q4 2022

Feb 14, 2023
BUY
$0.38 - $1.91 $87,272 - $438,660
229,665 Added 289.95%
308,874 $128,000
Q3 2022

Nov 10, 2022
BUY
$1.46 - $2.38 $7,282 - $11,871
4,988 Added 6.72%
79,209 $128,000
Q2 2022

Aug 11, 2022
BUY
$1.98 - $5.66 $146,957 - $420,090
74,221 New
74,221 $149,000

Others Institutions Holding SNCE

# of Institutions
2
Shares Held
43.3K
Call Options Held
0
Put Options Held
0
View Full List

About Science 37 Holdings, Inc.

SNCE Quotes by TradingView
  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email